Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Allograft rejection | R-HSA-9679028 | map05330 | buflomedil | 73341 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | buflomedil | 73341 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | buflomedil | 73341 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | buflomedil | 73341 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | buflomedil | 73341 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | buflomedil | 73341 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | buflomedil | 73341 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | buflomedil | 73341 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | bacampicillin | 5865 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | bacampicillin | 5865 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | bacampicillin | 5865 | drug-path |
Asthma | R-HSA-444620 | map05310 | bacampicillin | 5865 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | bacampicillin | 5865 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | bacampicillin | 5865 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | bacampicillin | 5865 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | bacampicillin | 5865 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | Prestwick-983 | None | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | Prestwick-983 | None | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | Prestwick-983 | None | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | nizatidine | 3033637 | drug-path |